A randomized phase III trial comparing triple weekly usage with weekly usage of paclitaxel in concurrent chemoradiotherapy for patients with locally advanced non-small cell lung cancer.

7545 Background: Optimum management of clinically locally advanced non-small cell lung cancer (LANSCLC) presents challenges because of the high local recurrence rate. NCCN guidelines recommend conc...